Skip to content

Study of the effects of food containing HYA on fasting blood glucose, triglyceride, LDL-cholesterol : an open-labeled pilot study

Study of the effects of food containing HYA on fasting blood glucose, triglyceride, LDL-cholesterol : an open-labeled pilot study - The effects of food containing HYA on fasting blood glucose, triglyceride, LDL-cholesterol.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019967
Enrollment
40
Registered
2015-11-27
Start date
2015-11-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Intake of food containing HYA for 12 weeks, 1 package per day.

Sponsors

TTC Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Males and females from 20 to 64 years of age (2) Subjects falling under any of the following criteria a. Fasting blood glucose levels are ranged from 100 mg/dL to 125 mg/dL b. Serum Triglyceride levels are ranged from 120 mg/dL to 199 mg/dL c. LDL-Cholesterol levels are ranged from 120 mg/dL to 159 mg/dL

Exclusion criteria

Exclusion criteria: (1) Subjects who routinely use health food containing large amount of fatty acids or health food for diet (2) Subjects who constantly use oral medication and/or functional foods which may affecting serum lipid levels, lipid metabolism and/or glycometabolism (3) Subjects who have under treatment or a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease) (4) Subjects having possibilities for emerging allergy related to the current study (5) Subjects having a disease requiring treatment or a history of serious diseases for which medication was required (6) Subjects who are judged as unsuitable for the current study based on the results of clinical and physical preliminary examination (7) Subjects who have participated in other clinical studies within the last one month prior to the current study or are planned to participate in other studies after obtaining informed consent for the current study (8) Subjects who intend to become pregnant or lactating (9) Subjects who are judged as unsuitable for the current study based on the results of lifestyle questionnaire (10) Subjects judged as unsuitable for the current study by the investigator

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose level, Triglyceride level and LDL-cholesterol level at weeks 4, 8 and 12 ingestion

Countries

Japan

Contacts

Public ContactShinsuke Tsuji

TTC Co., Ltd. Clinical Research Planning Department

s.tsuji@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026